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ABSTRACT 
     Introduction: Metabolites are the intermediate and natural low molecular weight products of metabolic 
reactions which naturally occur within cells. Metabolomics is a post-genomics study that analyzes 
metabolic profile in all biological samples. Gas chromatography-mass spectrometry (GC-MS) is a powerful 
technique that detects volatile components. This study evaluates the metabolite profile of serum with a 
simple method for derivatization. Methods: In this study, the metabolic profile of serum sample of 16 rats 
was analyzed using GC-MS after protein precipitation, using acetonitrile, and derivatize with a method of 
less in number and volume of materials. Acquisition chromatograms were pre-processed and analyzed using 
National Institute of Standards and Technology (NIST) library.Results: 35 metabolites with probability of 
>60% perfect match were detected according to spectrum fragments analysis by NIST library. 
Conclusion: This study represents the metabolome profile of serum instead of the change of metabolites that 
can be evaluated with a simple derivatization method.  
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INTRODUCTION 
     Metabolites are low-molecular-weight (<1 
kDa) components in the biological sample such as 
urine and serum [1]. The metabolites are small 
molecules which interfere in the biochemical 
pathway essential for growth, development and 
reproduction mechanisms [2]. The flux of 
information from gene activation to translation 
affects the level and fluctuation of metabolites. 
The concentration of metabolites at a given time 
can represent the state of the organism. 
Metabolomics or metabolome profiling is the 
quantitative and qualitative study of the 
metabolites that provides a considerable capacity 
for diagnostics [3]. This approach is an exclusive 
top-down approach for studying complex systems 
that evaluate the end result. [4]. Biomarker 
discovery in research and clinical conditions is an 
advantage of metabolomics that provide 
diagnostic and prognostic information [5]. The 
chromatographic techniques in combinations with 
mass spectrometry facilitated the analysis of 
metabolome [6]. Gas chromatography-mass 
spectrometry (GC-MS) is a powerful technique 
that extensively applies in metabolomics [7]. The 
volatile components are detectable in GC-MS 
analysis. Limitation of GC-MS in metabolomics 
is the study of nonvolatile components [8]. A 
derivatization reaction is necessary to generate 
them suitably for separation on GC column [9]. 
While the previous studies focused on either 
various materials or high volume of each material 
for derivatization [10-12] in the present study, 
this study attempted to decrease both the quantity 
of materials and the volume of each for 
derivatization. Further, total serum metabolome 
was assessed instead of measuring the change of 
metabolites by others. 




MATERIALS AND METHODS 
Reagents 
     Pyridine, methoxylamine hydrochloride, N-
methyl-N-(trimethylsilyl)- trifluoracetamide 
(MSTFA) and acetonitrile (HPLC grade) were 
purchased from Sigma-Aldrich (Poole, UK). 
Sample collection and preparation 
     In this experimental study, a total of 16 male 
Wistar rats serum sample were obtained from 
Physiology Research Center, Kashan University 
of Medical Sciences. Blood samples were 
collected from animals into tubes. After 10 min, 
the clot was separated and the solvent was 
centrifuged at 3000g for 10 min. Then the 
supernatant (300mL) was protein precipitated 
(room temperature for 15 min) using acetonitrile 
(1:3 v/v) followed by centrifugation (3000 rpm, 
10 min) at room temperature. All the acetonitrile 
solutions were clear after centrifugation 
indicating complete solubilization. An aliquot 
(400 mL) of the supernatant was evaporated to 
dryness under vacuum. All procedures were in 
accordance with the Guidelines of Ethical 
Committee, Deputy of Research, Kashan 
University of Medical Sciences, Kashan, Iran. 
Sample derivatization 
     Samples had to be derivatised before injection 
using methoxylamine hydrochloride (20 µL; 
40mg/mL in pyridine) at 28
o
C for 90 min, 




Gas chromatography/mass spectrometry 
(GC/MS) analysis 
     The sample was analyzed using an Agilent 
GC-MS system with Chemstation software. A 
sample of 1 μL was injected with a split ratio of 2 
into the GC and then separated with a fused silica 
HP-5MS capillary column (30 m, 0.25 mm inside 
diameter, 0.25 μm thickness of the inner liquid in 
the column). In the chromatographic part, the 
injector temperature was 270 °C and the helium 
with a purity of 99.999 was used as carrier gas 
with a flow rate of 1.5 mL/min. The column 
temperature condition was as follows: It was 
initially kept at 40 °C for 3 min, ramped to 280  
°C at 5 °C/min, and then held for 10 min. The 
inter-phase temperature and ion source 
temperature at mass spectrum were 180 and 150 
°C, respectively. The metabolomic analysis was 
performed in Chemistry and Chemical 
Engineering Research Center and Analytical 
Chemistry Research Center, Kashan University. 
 
DATA ANALYSIS 
     The total ion chromatograms (TIC) of all 
samples were extracted and subsequently 
imported into MATLAB environment for further 
data analysis. In order to remove different 
chromatographic artifacts, the obtained 
chromatograms were subjected to various pre-
processing steps including baseline correction 
performing by asymmetric least squares (AsLS) 
algorithm and peak alignment by Correlation 
Optimizing warping (COW). The pre-processed 
chromatograms were then mean-centered and 
paretoscaled. Finally, each compound was 
compared with National Institute of Standards 
and Technology (NIST) as the standard mass 
spectra library for identification of them. For each 
peak, the software generated a list of similarities; 
the similarity indexes more than 60% were 
assigned compound names.   
   
RESULTS 
     The spectrum of rat serum metabolites is 
depicted in figure 1. We detected about 35 
metabolites in serum sample. All of the 
metabolites detected by GC-MS were identified 
using mass spectral libraries. The commercially 
available library, NIST, was used for 
identification of detected metabolites. According 
to spectrum fragments and its retention times, the 
derived metabolites are matched to the library and 
all fragments scored with a match probability 
percent. The probability of >60% was regarded as 
a perfect match (table 1). There are 35 
metabolites detected through this study with 
probability of > 60%. Because of derivatization, 
all metabolites with trimethylsilyl are reported as 
suffix or pref





Figure1. The chromatogram of rat serum using GC-MS 
             Table 1. The metabolites of rat serum detected by GC-MS and using NIST library 
RT 
(min) 
Elemental composition Prob. MW Description from best library match 
7.971 C8H24O2Si3 89 236 Trisiloxane, octamethyl 
8.106 C7H21NSi2 96 175 Silanamine, N,1,1,1-tetramethyl-N-(trimethylsilyl)- 
9.775 C7H21NOSi2 95 191 Silanamine, N-methoxy-1,1,1-trimethyl-N-(trimethylsilyl)- 
10.83 C7H18N2Si2 89 186 Silanamine, N,N'-methanetetraylbis[1,1,1-trimethyl- 
11.558 C8H22O2Si2 73 206 1,2-Bis(trimethylsiloxy)ethane 
13.7 C7H15NO3Si 70 189 Propanoic acid, 2-(methoxyimino)-, trimethylsilyl ester 
14.49 C8H20O3Si2 67 220 Acetic acid, [(trimethylsilyl)oxy]-, trimethylsilyl ester 
14.917 C8H19NO2Si 87 189 l-Valine, trimethylsilyl ester 
16.143 C10H30O5Si5 88 370 Cyclopentasiloxane, decamethyl- 
16.977 C10H24O3Si2 78 248 Butanoic acid, 3-[(trimethylsilyl)oxy]-, trimethylsilyl ester 
17.045 C12H36O4Si5 80 384 Pentasiloxane, dodecamethyl- 
19.671 C7H20N2OSi2 90 204 Urea, N,N'-bis(trimethylsilyl)- 
20.172 C12H32O3Si3 76 308 Trimethylsilyl ether of glycerol 
20.352 C9H27O4PSi3 91 314 Silanol, trimethyl-, phosphate (3:1) 
20.884 C12H36O6Si6 97 444 Cyclohexasiloxane, dodecamethyl- 
21.023 C11H29NO2Si3 83 291 Glycine, N,N-bis(trimethylsilyl)-, trimethylsilyl ester 
21.718 C12H30O4Si3 71 322 Propanoic acid, 2,3-bis[(trimethylsilyl)oxy]-, trimethylsilyl 
22.645 C12H26O2Si 60 230 Nonanoic acid, trimethylsilyl ester 
25.103 C13H28O2Si 60 244 Decanoic acid, trimethylsilyl ester 
25.165 C14H42O7Si7 94 518 Cycloheptasiloxane, tetradecamethyl- 
26.679 C11H23NO3Si2 78 273 L-Proline, 5-oxo-1-(trimethylsilyl)-, trimethylsilyl ester 
28.999 C16H48O8Si8 74 592 Cyclooctasiloxane, hexadecamethyl- 
29.078 C15H39NO3Si3 68 365 Triethylamine, 2,2',2''-tris(trimethylsiloxy)- 
30.574 C14H22O4Si2 94 310 1,2-Benzenedicarboxylic acid, bis(trimethylsilyl) ester 
32.85 C15H32O4Si2 60 332 Azelaic acid, bis(trimethylsilyl) ester 
33.924 C17H36O2Si 71 300 Tetradecanoic acid, trimethylsilyl ester 
37.785 C19H40O2Si 88 328 Hexadecanoic acid, trimethylsilyl ester 
38.301 C24H60O6Si6 75 612 Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-, scyllo- 
38.398 C17H27NO2Si2 97 333 1H-Indole-3-propanoic acid, 1-(trimethylsilyl)-, trimethylsilyl 
40.727 C21H40O2Si 69 352 9,12-Octadecadienoic acid (Z,Z)-, trimethylsilyl ester 
41.271 C21H44O2Si 88 356 Octadecanoic acid, trimethylsilyl ester 
43.789 C23H50O4Si2 90 446 Myristic acid, 2,3-bis(trimethylsiloxy)propyl ester 




46.267 C25H54O4Si2 76 474 2-Monopalmitin trimethylsilyl ether 
46.794 C25H54O4Si2 95 474 Hexadecanoic acid, 2,3-bis[(trimethylsilyl)oxy]propyl ester 
55.53 C30H54OSi 71 458 Cholesterol trimethylsilyl ether 
 
DISCUSSION 
     A metabolite is any intermediate and small 
molecules substance produced during 
metabolism. Metabolite may also refer to the 
product resulting from drug metabolization by the 
body [13, 14]. They have various functions in the 
body including fuel, structure, signaling, 
stimulation and inhibition of enzymes. Also, it is 
directly involved in normal growth, development, 
and reproduction [15, 16].  
This study aimed at evaluating the metabolite 
profile of serum, using GC-MS technique with a 
modified method with less amount and volume 
materials for derivatization. It revealed that there 
are 35 metabolites in serum with probability of up 
to 60%, known as a perfect match. 
Metabolomics is a procedure which evaluates the 
metabolites in various conditions and determines 
system response to perturbations [17]. This 
approach profiles metabolites in different 
physiological states and can be used to monitor 
the changes of metabolites in biofluids [18]. Gas 
chromatography coupled with mass spectrometry 
(GC-MS) is a common analytical tool in 
metabolomics which provides high separation 
efficiency for biological mixtures [19]. Many 
investigations used various or high amounts of 
materials for sample derivatization. Ruoxu Liu 
and his co-workers used ribitol, methanol, 
chloroform, deionized water, N2 gas, 
metoxyamine hydrochloride, MSTFA and TMCS 
for derivatization [10]. While previous studies 
reported that 200µL of MSTFA is required for 
derivatization,  the present study proved that 80 
µL of MSTFA could be sufficient enough for the 
process [12]. However, the present study suggests 
a method with decreased quantity and volume of 
materials for derivatization. Moreover,  total 
metabolome of serum instead the change of 
metabolites is presented which is measured in 
some other studies [20, 21]. This study, similar to 
some other studies detected 35 metabolites were 
which almost near to findings of others; however, 
it would be a limitation of this study where there 







     This study represents the metabolome profile 
of serum instead the change of metabolites that 
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